Učitavanje...
Efficacy of the monoclonal antibody EGFR inhibitors for the treatment of metastatic colorectal cancer
Two anti-epidermal growth factor receptor (EGFR) monoclonal antibodies (MoAbs) have been approved in Canada for the treatment of metastatic colorectal cancer (mCRC) – cetuximab, a mouse-human chimeric MoAb, and panitumumab, a fully human MoAb. This paper reviews the efficacy of the anti-EGFR monoclo...
Spremljeno u:
| Format: | Članak |
|---|---|
| Jezik: | en |
| Izdano: |
Multimed Inc.
2010
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2901794/ https://ncbi.nlm.nih.gov/pubmed/20680105 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|